000

DONGKOOK PHARMACEUTICAL CO.,LTD.

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪767.34 B‬KRW
1,400KRW
‪47.18 B‬KRW
‪730.99 B‬KRW
‪23.66 M‬
Beta (1Y)
−0.02
Employees (FY)
‪1.13 K‬
Revenue / Employee (1Y)
‪497.26 K‬KRW
Net income / Employee (1Y)
‪32.09 K‬KRW

About DONGKOOK PHARMACEUTICAL CO.,LTD.


CEO
Joon-Ho Song
Headquarters
Seoul
Founded
1968
ISIN
KR7086450004
FIGI
BBG000R6HNL4
DongKook Pharmaceutical Co., Ltd. engages in the manufacture and sale of pharmaceuticals. Its products include raw materials and finished products of pharmaceuticals, health care products, and medical devices. The company was founded on October 15, 1968 and is headquartered in Seoul, South Korea.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 086450 is 17,460 KRW — it has decreased by −0.57% in the past 24 hours. Watch DONGKOOK PHARMACEUTICAL CO.,LTD. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange DONGKOOK PHARMACEUTICAL CO.,LTD. stocks are traded under the ticker 086450.
086450 stock has risen by 3.37% compared to the previous week, the month change is a −2.35% fall, over the last year DONGKOOK PHARMACEUTICAL CO.,LTD. has showed a 14.12% increase.
We've gathered analysts' opinions on DONGKOOK PHARMACEUTICAL CO.,LTD. future price: according to them, 086450 price has a max estimate of 23,000.00 KRW and a min estimate of 23,000.00 KRW. Watch 086450 chart and read a more detailed DONGKOOK PHARMACEUTICAL CO.,LTD. stock forecast: see what analysts think of DONGKOOK PHARMACEUTICAL CO.,LTD. and suggest that you do with its stocks.
086450 reached its all-time high on Sep 10, 2020 with the price of 36,150 KRW, and its all-time low was 1,500 KRW and was reached on Oct 28, 2008. View more price dynamics on 086450 chart.
See other stocks reaching their highest and lowest prices.
086450 stock is 1.32% volatile and has beta coefficient of −0.02. Track DONGKOOK PHARMACEUTICAL CO.,LTD. stock price on the chart and check out the list of the most volatile stocks — is DONGKOOK PHARMACEUTICAL CO.,LTD. there?
Today DONGKOOK PHARMACEUTICAL CO.,LTD. has the market capitalization of ‪767.69 B‬, it has decreased by −2.61% over the last week.
Yes, you can track DONGKOOK PHARMACEUTICAL CO.,LTD. financials in yearly and quarterly reports right on TradingView.
DONGKOOK PHARMACEUTICAL CO.,LTD. revenue for the last quarter amounts to ‪198.40 B‬ KRW, despite the estimated figure of ‪198.40 B‬ KRW. In the next quarter, revenue is expected to reach ‪195.80 B‬ KRW.
086450 net income for the last quarter is ‪19.30 B‬ KRW, while the quarter before that showed ‪13.61 B‬ KRW of net income which accounts for 41.79% change. Track more DONGKOOK PHARMACEUTICAL CO.,LTD. financial stats to get the full picture.
Yes, 086450 dividends are paid annually. The last dividend per share was 180.00 KRW. As of today, Dividend Yield (TTM)% is 1.03%. Tracking DONGKOOK PHARMACEUTICAL CO.,LTD. dividends might help you take more informed decisions.
DONGKOOK PHARMACEUTICAL CO.,LTD. dividend yield was 1.11% in 2023, and payout ratio reached 16.77%. The year before the numbers were 1.08% and 14.96% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 24, 2024, the company has ‪1.13 K‬ employees. See our rating of the largest employees — is DONGKOOK PHARMACEUTICAL CO.,LTD. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. DONGKOOK PHARMACEUTICAL CO.,LTD. EBITDA is ‪109.34 B‬ KRW, and current EBITDA margin is 12.03%. See more stats in DONGKOOK PHARMACEUTICAL CO.,LTD. financial statements.
Like other stocks, 086450 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade DONGKOOK PHARMACEUTICAL CO.,LTD. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So DONGKOOK PHARMACEUTICAL CO.,LTD. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating DONGKOOK PHARMACEUTICAL CO.,LTD. stock shows the neutral signal. See more of DONGKOOK PHARMACEUTICAL CO.,LTD. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.